MedTrace Logo

Prospective Study on the Role of Eus-fnb in the Diagnosis of Autoimmune Pancreatitis

NCT04397731 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 52

Last updated 2025-02-07

No results posted yet for this study

Summary

According to the reported histological procurement yield of the end-cutting needles, the investigators supposed that the use of EUS-FNB in probable AIP patients, generally aimed only to rule-out malignancy, could provide histological tissue samples useful in enhancing the diagnostic level reached without histology, or defining the type of AIP.

Conditions

  • Autoimmune Pancreatitis

Sponsors & Collaborators

  • Azienda Ospedaliera Universitaria Integrata Verona

    lead OTHER

Principal Investigators

  • Stefano Francesco Crinò · Azienda Ospedaliera Integrata Verona

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2022-06-01
Completion
2023-06-01

Countries

  • Italy
  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04397731 on ClinicalTrials.gov